New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt

Details for Australian Patent Application No. 2005257709 (hide)

Owner AstraZeneca AB

Inventors Noreland, Ursula; Bohlin, Martin

Agent Freehills

Pub. Number AU-B-2005257709

PCT Pub. Number WO2006/001753

Priority 60/582,617 24.06.04 US

Filing date 20 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 13 November 2008

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2006/001753 Priority application(s): WO2006/001753

13 November 2008 Application Accepted

  Published as AU-B-2005257709

12 March 2009 Standard Patent Sealed

30 September 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 03 Sep 2010. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Melbourne VIC 3000

24 February 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 Sep 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005257715-Means and method for detection of blood leakage from wounds

2005257708-Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor CCR5